Follow the Zai Lab Ltd. share price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are quoted on the HK market, under the authority of HKEX. Operating in the Health Care sector, Zai Lab Ltd. has logged 38 reports. Market capitalisation: €23.1bn. The latest transaction was reported on 14 August 2026 (Sale). Among the most active insiders: Du Ying. All data is free.
38
Insider Decl.
n/a
Thresholds
€7,340
12 ops.
Buy Volume
€29m
13 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Zai Lab Ltd. Strong Buy (bullish), based on 10 analysts. Average price target: HK$21.01.
29Σ signal
Buys €7,340€29m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,541 of 28,685 companies
31.7
score / 100
Value
32
Quality
31
FCF yld-0.7%
Earn yld-0.8%
EV/EBITDA·
ROE-27%
Gross mgn58%
Net mgn-38%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Zai Lab Ltd. is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It is listed on the Hong Kong Stock Exchange.